ProPhase Labs, Inc. — Director's Dealing 2022

May 23, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2022-05-23

Reporting Person: White Billy Joe (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$6.74	2029-05-09	Common Stock, par value $0.0005 (400000)		Direct

Footnotes

F1: Stock option granted as an inducement award. The option will vest over a four year period, with 12.5% vesting every six months after May 23, 2022, the date the Reporting Person's employment commenced, contingent upon his continued service through each vesting date.